Trials / Unknown
UnknownNCT01267149
A Clinical Study Evaluaing the Efficacy, Safety, and Patient Satisfaction of Injectable Hylaronic Acid With 0.3% Lidocain Hydrochloride, Prevelle Silk, for Superficial, Vertical Perioral Lines and Superficial, Horizontal, Lateral Canthal Lines
Phase 4 Study - A Clinical Study Evaluaing the Efficacy, Safety, and Patient Satisfaction of Injectable Hylaronic Acid With 0.3% Lidocain Hydrochloride, Prevelle Silk, for Superficial, Vertical Perioral Lines and Superficial, Horizontal, Lateral Canthal Lines
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 13 (estimated)
- Sponsor
- Goldman, Butterwick, Fitzpatrick and Groff · Academic / Other
- Sex
- All
- Age
- 35 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Statistical Hypotheses The Null Hypothesis: There is no difference in the reduction of lines in the treated areas as compared to baseline. Alternative Hypothesis: There is a difference in the reduction of lines in the treated areas as compared to baseline.
Conditions
Timeline
- Start date
- 2010-08-01
- First posted
- 2010-12-28
- Last updated
- 2010-12-28
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01267149. Inclusion in this directory is not an endorsement.